NCT01444482View on ClinicalTrials.gov

Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

Matrix M

1 human dose of seasonal influenza vaccine formulated with 50 µg Matrix M, total dosage volume 0.55 mL injected intramuscularly in the upper arm once at day 0.

BIOLOGICAL

Seasonal influenza vaccine

1 human dose of seasonal influenza vaccine

Trial Locations (1)

8231

Drug Reseach Center, Balatonfüred

Sponsors

Lead Sponsor

Isconova AB
All Listed Sponsors
lead

Isconova AB

INDUSTRY